Back to Archived Journals » Core Evidence » Volume 14
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 14, 2019
Pertuzumab in the treatment of HER2-positive breast cancer: an evidence-based review of its safety, efficacy, and place in therapy
Ishii K, Morii N, Yamashiro H
Core Evidence 2019, 14:51-70
Published Date: 31 October 2019
Anabolics in the management of glucocorticoid-induced osteoporosis: an evidence-based review of long-term safety, efficacy and place in therapy
Taylor AD, Saag KG
Core Evidence 2019, 14:41-50
Published Date: 23 August 2019
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy
Bassetti M, Castaldo N, Carnelutti A, Peghin M, Giacobbe DR
Core Evidence 2019, 14:31-40
Published Date: 5 July 2019
Lomitapide: a review of its clinical use, efficacy, and tolerability
Alonso R, Cuevas A, Mata P
Core Evidence 2019, 14:19-30
Published Date: 1 July 2019
Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy
Galkin M, Jonas BA
Core Evidence 2019, 14:3-17
Published Date: 26 April 2019
Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review [Erratum]
Beccari MV, Meaney CJ
Core Evidence 2019, 14:1-2
Published Date: 27 February 2019